Search research articles
Contact Us
Filters
Showing results (61-70 of 103) with videos related to
Page
of 11
Sort By:
The Journal of Experimental Medicine
|
April 23, 2014
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies
Francois H T Duong, Gaia Trincucci, Tujana Boldanova, et al.
Journal of Hepatology
|
October 12, 2010
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Andrew J Syder, Haekyung Lee, Mirjam B Zeisel, et al.
Hepatology (Baltimore, Md.)
|
May 27, 2015
Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties
Rajiv G Tawar, Che C Colpitts, Jörg Timm, et al.
Journal of Virology
|
August 22, 2014
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins
Dorothea Bankwitz, Gabrielle Vieyres, Kathrin Hueging, et al.
The Journal of Biological Chemistry
|
July 7, 2012
Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps
Viet Loan Dao Thi, Christelle Granier, Mirjam B Zeisel, et al.
Antiviral Research
|
January 2, 2019
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection
Laurent Mailly, Florian Wrensch, Laura Heydmann, et al.
Journal of Virology
|
April 2, 2010
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes
Dorothea Bankwitz, Eike Steinmann, Julia Bitzegeio, et al.
The Journal of Biological Chemistry
|
July 31, 2015
Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model
Sara Calattini, Floriane Fusil, Jimmy Mancip, et al.
Gut
|
May 23, 2014
Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
Fei Xiao, Isabel Fofana, Christine Thumann, et al.
Journal of Virology
|
January 25, 2008
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells
Heidi Barth, Eva K Schnober, Christoph Neumann-Haefelin, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 103) with videos related to
Sort By:
Page
of 11
The Journal of Experimental Medicine
|
April 23, 2014
IFN-λ receptor 1 expression is induced in chronic hepatitis C and correlates with the IFN-λ3 genotype and with nonresponsiveness to IFN-α therapies
Francois H T Duong, Gaia Trincucci, Tujana Boldanova, et al.
Journal of Hepatology
|
October 12, 2010
Small molecule scavenger receptor BI antagonists are potent HCV entry inhibitors
Andrew J Syder, Haekyung Lee, Mirjam B Zeisel, et al.
Hepatology (Baltimore, Md.)
|
May 27, 2015
Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties
Rajiv G Tawar, Che C Colpitts, Jörg Timm, et al.
Journal of Virology
|
August 22, 2014
Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins
Dorothea Bankwitz, Gabrielle Vieyres, Kathrin Hueging, et al.
The Journal of Biological Chemistry
|
July 7, 2012
Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps
Viet Loan Dao Thi, Christelle Granier, Mirjam B Zeisel, et al.
Antiviral Research
|
January 2, 2019
In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection
Laurent Mailly, Florian Wrensch, Laura Heydmann, et al.
Journal of Virology
|
April 2, 2010
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes
Dorothea Bankwitz, Eike Steinmann, Julia Bitzegeio, et al.
The Journal of Biological Chemistry
|
July 31, 2015
Functional and Biochemical Characterization of Hepatitis C Virus (HCV) Particles Produced in a Humanized Liver Mouse Model
Sara Calattini, Floriane Fusil, Jimmy Mancip, et al.
Gut
|
May 23, 2014
Synergy of entry inhibitors with direct-acting antivirals uncovers novel combinations for prevention and treatment of hepatitis C
Fei Xiao, Isabel Fofana, Christine Thumann, et al.
Journal of Virology
|
January 25, 2008
Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells
Heidi Barth, Eva K Schnober, Christoph Neumann-Haefelin, et al.
Page
of 11